Pulmonx Corp. (LUNG)
2.065
-0.02
(-0.72%)
USD |
NASDAQ |
Sep 09, 13:07
Pulmonx Total Liabilities (Quarterly) : 75.54M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 75.54M |
| March 31, 2026 | 74.20M |
| December 31, 2025 | 79.84M |
| September 30, 2025 | 78.25M |
| June 30, 2025 | 78.10M |
| March 31, 2025 | 73.07M |
| December 31, 2024 | 81.90M |
| September 30, 2024 | 73.48M |
| June 30, 2024 | 71.44M |
| March 31, 2024 | 54.09M |
| December 31, 2023 | 60.64M |
| September 30, 2023 | 59.27M |
| June 30, 2023 | 59.16M |
| March 31, 2023 | 57.34M |
| Date | Value |
|---|---|
| December 31, 2022 | 40.08M |
| September 30, 2022 | 38.72M |
| June 30, 2022 | 40.55M |
| March 31, 2022 | 40.70M |
| December 31, 2021 | 42.41M |
| September 30, 2021 | 43.99M |
| June 30, 2021 | 39.02M |
| March 31, 2021 | 38.66M |
| December 31, 2020 | 37.57M |
| September 30, 2020 | 70.53M |
| June 30, 2020 | 272.49M |
| March 31, 2020 | |
| December 31, 2019 | 240.91M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Abbott Laboratories | 57.45B |
| AngioDynamics, Inc. | 96.34M |
| Alphatec Holdings, Inc. | 779.49M |
| AtriCure, Inc. | 160.21M |
| Baxter International, Inc. | 13.61B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 114.73M |
| Shareholders Equity (Quarterly) | 39.20M |
| Debt to Equity Ratio | 1.434 |
| Current Ratio | 4.319 |
| Net Debt Paydown Yield | 0.26% |